131 related articles for article (PubMed ID: 26498461)
1. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
Vockerodt M; Tesch H; Kube D
Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
[TBL] [Abstract][Full Text] [Related]
3. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
[TBL] [Abstract][Full Text] [Related]
4. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
[TBL] [Abstract][Full Text] [Related]
5. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.
Uchihara JN; Matsuda T; Okudaira T; Ishikawa C; Masuda M; Horie R; Watanabe T; Ohta T; Takasu N; Mori N
Int J Cancer; 2006 Mar; 118(5):1098-107. PubMed ID: 16152613
[TBL] [Abstract][Full Text] [Related]
7. Relationship between constitutive nuclear factor-kappaB (NF-kappaB) and inhibitor kappaB-alpha (IkappaB-alpha) in an interferon-alpha-sensitive human Burkitt lymphoma cell line.
Rath PC
Biochim Biophys Acta; 2005 Sep; 1741(3):253-63. PubMed ID: 15979856
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Ito K; Morisita Y; Watanabe M; Ishida T; Higashihara M; Kadin M; Watanabe T
Am J Pathol; 2002 May; 160(5):1647-54. PubMed ID: 12000717
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1.
Uchihara JN; Krensky AM; Matsuda T; Kawakami H; Okudaira T; Masuda M; Ohta T; Takasu N; Mori N
Int J Cancer; 2005 May; 114(5):747-55. PubMed ID: 15609310
[TBL] [Abstract][Full Text] [Related]
10. Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.
Okudaira T; Yamamoto K; Kawakami H; Uchihara JN; Tomita M; Masuda M; Matsuda T; Sairenji T; Iha H; Jeang KT; Matsuyama T; Takasu N; Mori N
Br J Haematol; 2006 Feb; 132(3):293-302. PubMed ID: 16409294
[TBL] [Abstract][Full Text] [Related]
11. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T
Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB.
Ishikawa C; Mori N
Int J Oncol; 2013 May; 42(5):1786-92. PubMed ID: 23546309
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
15. Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts.
Nonaka M; Horie R; Itoh K; Watanabe T; Yamamoto N; Yamaoka S
Oncogene; 2005 Jun; 24(24):3976-86. PubMed ID: 15782119
[TBL] [Abstract][Full Text] [Related]
16. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
[TBL] [Abstract][Full Text] [Related]
17. The biological basis of Hodgkin's lymphoma.
Horie R; Watanabe T
Drug News Perspect; 2003 Dec; 16(10):649-56. PubMed ID: 14747844
[TBL] [Abstract][Full Text] [Related]
18. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
Kis LL; Gerasimcik N; Salamon D; Persson EK; Nagy N; Klein G; Severinson E; Klein E
Blood; 2011 Jan; 117(1):165-74. PubMed ID: 20876453
[TBL] [Abstract][Full Text] [Related]
19. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.
Karlsen JR; Borregaard N; Cowland JB
J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144
[TBL] [Abstract][Full Text] [Related]
20. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]